We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+10.93%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.18B
AUM Growth
-$2.44B
(-43%)
Cap. Flow
-$2.85B
Cap. Flow
% of AUM
-89.66%
Top 10 Holdings %
Top 10 Hldgs %
60.78%
Holding
672
New
112
Increased
61
Reduced
251
Closed
169
Avg Time Held Equity + Options
4.1
quarters
Top 10 Avg Time Held Equity + Options
0.1
quarters
Top 20 Avg Time Held Equity + Options
0.6
quarters
Avg Time Held Equity only
4.3
quarters
Top 10 Avg Time Held Equity only
0.1
quarters
Top 20 Avg Time Held Equity only
0.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pioneer Natural Resource Co.
PXD
|
+$604M |
| 2 |
Splunk Inc
SPLK
|
+$446M |
| 3 |
Hess
HES
|
+$339M |
| 4 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
+$106M |
| 5 |
US Steel
X
|
+$50.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$1.06B |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$887M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$371M |
| 4 |
VMW
VMware, Inc
VMW
|
+$354M |
| 5 |
NEWR
New Relic, Inc.
NEWR
|
+$284M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 29.51% |
| 2 | Technology | 21.97% |
| 3 | Healthcare | 10.49% |
| 4 | Miscellaneous | 10.26% |
| 5 | Real Estate | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
DELISTED
Sizzle Acquisition Corp. Common stock
SZZL
| $1.76M | 0.06% |
159,437
-71,665
| -31% | -$783K |
2022 Q1
7 quarters
|
|
177
DELISTED
Perception Capital Corp. IV
RCFA
| $1.75M | 0.06% |
159,438
-71,664
| -31% | -$787K |
2022 Q1
7 quarters
|
|
178
NetEase
NTES
$79.6B
| $1.75M | 0.06% |
+18,790
| New | +$2M |
2023 Q4
0 quarters
|
|
179
DELISTED
Direct Selling Acquisition Corp.
DSAQ
| $1.75M | 0.06% |
160,685
-72,226
| -31% | -$786K |
2021 Q4
8 quarters
|
|
180
DELISTED
TLGY Acquisition Corporation Class A Ordinary Share
TLGY
| $1.74M | 0.05% |
156,317
-70,262
| -31% | -$775K |
2022 Q1
7 quarters
|
|
|
VEEA
181
Veea Inc
VEEA
$17.7M
| $1.74M | 0.05% |
7,972
-3,583
| -31% | -$773K |
2021 Q2
10 quarters
|
|
182
Highwoods Properties
HIW
$3.2B
| $1.73M | 0.05% |
75,224
+45,224
| +151% | +$901K |
2023 Q1
3 quarters
|
|
183
Inspire Medical Systems
INSP
$1.99B
| $1.73M | 0.05% |
8,485
-4,086
| -33% | -$662K |
2022 Q3
5 quarters
|
|
184
Pinduoduo
PDD
$116B
| $1.73M | 0.05% |
11,795
-19,169
| -62% | -$2.32M |
2022 Q3
5 quarters
|
|
185
DELISTED
Investcorp Europe Acquisition Corp I Class A Ordinary Shares
IVCB
| $1.72M | 0.05% |
156,317
-70,262
| -31% | -$771K |
2022 Q1
7 quarters
|
|
186
VICI Properties
VICI
$25.2B
| $1.72M | 0.05% |
53,992
-168,995
| -76% | -$4.96M |
2023 Q1
3 quarters
|
|
187
DELISTED
Fintech Ecosystem Development Corp. Class A Common Stock
FEXD
| $1.71M | 0.05% |
159,438
-71,664
| -31% | -$767K |
2022 Q1
7 quarters
|
|
188
DELISTED
CSLM Acquisition Corp. Class A Ordinary Share
CSLM
| $1.7M | 0.05% |
156,317
-70,262
| -31% | -$758K |
2022 Q1
7 quarters
|
|
|
TGVC
189
DELISTED
TG Venture Acquisition Corp. Class A Common Stock
TGVC
| $1.7M | 0.05% |
156,317
-70,262
| -31% | -$762K |
2021 Q4
8 quarters
|
|
190
DELISTED
Arogo Capital Acquisition Corp. Class A Common Stock
AOGO
| $1.68M | 0.05% |
156,317
-70,262
| -31% | -$752K |
2022 Q2
6 quarters
|
|
191
Vera Therapeutics
VERA
$2.15B
| $1.65M | 0.05% |
106,972
-71,019
| -40% | -$902K |
2023 Q1
3 quarters
|
|
192
Sutro Biopharma
STRO
$237M
| $1.62M | 0.05% |
37,834
+4,834
| +15% | +$153K |
2023 Q3
1 quarter
|
|
193
Silence Therapeutics
SLN
$613M
| $1.62M | 0.05% |
93,198
-5,128
| -5% | -$57.6K |
2022 Q2
6 quarters
|
|
194
On Holding
ONON
$11.7B
| $1.62M | 0.05% |
60,000
-235,000
| -80% | -$6.4M |
2023 Q3
1 quarter
|
|
195
Mineralys Therapeutics
MLYS
$2.07B
| $1.6M | 0.05% |
+186,168
| New | +$1.46M |
2023 Q4
0 quarters
|
|
196
Scholar Rock
SRRK
$5.14B
| $1.6M | 0.05% |
85,129
-127,452
| -60% | -$1.58M |
2022 Q2
6 quarters
|
|
197
DELISTED
Finnovate Acquisition Corp. Class A Ordinary Shares
FNVT
| $1.59M | 0.05% |
143,494
-64,498
| -31% | -$708K |
2021 Q4
8 quarters
|
|
198
DELISTED
Esperion Therapeutics
ESPR
| $1.58M | 0.05% |
527,123
-104,824
| -17% | -$136K |
2022 Q3
5 quarters
|
|
199
DELISTED
Paragon 28, Inc.
FNA
| $1.57M | 0.05% |
126,645
-4,640
| -4% | -$49.1K |
2023 Q1
3 quarters
|
|
200
ADT
ADT
$4.7B
| $1.57M | 0.05% |
229,607
| – | – |
2018 Q2
22 quarters
|
|
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q4 2023 Portfolio in Review
As of Q4 2023, UBS O'Connor held 672 positions worth $3.18B, down 43% from $5.62B the previous quarter. Its ten largest holdings account for 61% of the portfolio.
UBS O'Connor withdrew a net $2.85B in Q4 2023, closing 169 positions and reducing 251 holdings. Its most notable exit was Activision Blizzard, an estimated $1.06B position sold in full.
By sector, the portfolio is most concentrated in Energy at 30% of assets, up from 3.6% a quarter earlier, followed by Technology and Healthcare.
Against the trend, UBS O'Connor opened a new position in Pioneer Natural Resource Co. worth $579M.
- UBS O'Connor's largest Q4 2023 buy was Pioneer Natural Resource Co.: 2,576,808 shares worth $579M.
- UBS O'Connor added most to Splunk Inc in Q4 2023, an estimated $446M increase.
- UBS O'Connor's biggest Q4 2023 reduction was Capri Holdings, cutting an estimated $36.6M.
- UBS O'Connor fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- UBS O'Connor's ten largest holdings make up 61% of its $3.18B portfolio in Q4 2023.
- UBS O'Connor opened 112 new positions and closed 169 in Q4 2023.
- UBS O'Connor's portfolio value fell 43% quarter-over-quarter to $3.18B.
Based on UBS O'Connor's 13F filing for Q4 2023, filed 14 Feb 2024.